Skip to main content
RTW Biotech Opportunities Ltd logo

RTW Biotech Opportunities Ltd — Investor Relations & Filings

Ticker · RTW ISIN · GG00BKTRRM22 LEI · 549300Q7EXQQH6KF7Z84 IL Financial and insurance activities
Filings indexed 545 across all filing types
Latest filing 2025-05-29 Transaction in Own Shar…
Country GG Guernsey
Listing IL RTW

About RTW Biotech Opportunities Ltd

https://www.rtwfunds.com/rtw-biotech-op…

RTW Biotech Opportunities Ltd is an investment fund that focuses on identifying and investing in transformative assets with high growth potential across the global life sciences sector. The company's portfolio is primarily composed of biotechnology and medical technology companies. Managed by RTW Investments, LP, a specialized life sciences investment firm, the fund leverages deep scientific expertise to support companies throughout their entire lifecycle, from early-stage private ventures to publicly traded entities. The investment strategy aims to provide capital and strategic support to advance the development of innovative therapies and technologies.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from RTW Biotech Opportunities Ltd regarding the repurchase of 100,000 of its own ordinary shares to be held in treasury. The text explicitly mentions 'Transaction in Own Shares' as the title and details the number of shares bought, the price, and the impact on total voting rights. This aligns perfectly with the definition for the 'POS' (Transaction in Own Shares) filing category.
2025-05-29 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from RTW Biotech Opportunities Ltd regarding the repurchase of 100,000 of its own ordinary shares to be held in treasury. The text explicitly mentions 'Transaction in Own Shares' as the title and details the number of shares bought, the price, and the impact on total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-05-27 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from RTW Biotech Opportunities Ltd regarding the repurchase of 100,000 of its own Ordinary Shares. It details the price per share, the total number of shares held in treasury, and the resulting total voting rights. This falls directly under the definition of 'Transaction in Own Shares' (POS), as it reports the company buying back its own shares.
2025-05-22 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from RTW Biotech Opportunities Ltd regarding the repurchase of 100,000 of its own ordinary shares to be held in treasury. The text explicitly mentions 'Transaction in Own Shares' in the title and details the number of shares bought, the price, and the impact on total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-05-21 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from RTW Biotech Opportunities Ltd regarding the repurchase of 100,000 of its own ordinary shares to be held in treasury. The text explicitly mentions 'Transaction in Own Shares' as the title and details the number of shares bought, the price, and the impact on total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-05-20 English
Update on Rocket Pharmaceuticals
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement issued by RTW Biotech Opportunities Ltd. It provides an update on a portfolio company, Rocket Pharmaceuticals, regarding clinical trial data. It does not constitute a full financial report, audit, or proxy statement. As it is a general regulatory announcement regarding company news that does not fit into more specific categories like M&A or dividends, it is classified as a Regulatory Filing (RNS).
2025-05-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.